Augustine Lawlor - Chief Operating Officer at Leap Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
LPTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Augustine Lawlor since 8/16/2023

Holdings reported by Augustine Lawlor for Leap Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 414K $1.18M $2.85 Jan 26, 2024 By HealthCare Ventures IX, L.P.
Common Stock 262K $746K $2.85 Jan 26, 2024 HCV VIII Liquidating Trust
Common Stock 5.09K $14.5K $2.85 Jan 26, 2024 Direct
Restricted Stock Units 0 $0 $2.85 Jan 26, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 85K Jan 29, 2024 Direct Common Stock

Transactions reported by Augustine Lawlor for Leap Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership